Clinical Trials Directory

Trials / Unknown

UnknownNCT05363410

Micronutrient Supplement for Nurse Burnout

Quantifying the Effects of MagnéVie B6® on Stress and Burnout Among Nurses During the COVID-19 Pandemic: A Randomized Double Blind Placebo-Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
Nutraceuticals Research Institute · Academic / Other
Sex
Female
Age
20 Years – 59 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to confirm and quantify the ability of an 8-week intervention with a supplement containing magnesium citrate and vitamin B6 to reduce anxiety, stress, and burnout among nurses working full time in hospitals and urgent care centers during the COVID-19 Pandemic.

Detailed description

After being informed about the study and potential risks, all participants woh meet the eligibility criteria will provide written informed consent. They will then be randomized in a 1:1 ratio to either MagnéVie B6® or a placebo group. The assigned product will be consumed 3 times daily for 8 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMagnéVie B6®micronutrient supplement
OTHERPlaceboplacebo supplement

Timeline

Start date
2022-05-01
Primary completion
2022-09-30
Completion
2023-04-30
First posted
2022-05-05
Last updated
2022-05-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05363410. Inclusion in this directory is not an endorsement.